Cargando…

NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases

Due to their potent immunoregulatory and angio-modulatory properties, mesenchymal stem cells (MSCs) and their exosomes (MSC-Exos) have emerged as potential game-changers in regenerative ophthalmology, particularly for the personalized treatment of inflammatory diseases. MSCs suppress detrimental imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrell, Carl Randall, Djonov, Valentin, Antonijevic, Ana, Volarevic, Vladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529394/ https://www.ncbi.nlm.nih.gov/pubmed/37759549 http://dx.doi.org/10.3390/cells12182327

Ejemplares similares

Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022)

The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Modulation of Obstructive Sleep Apnea
por: Zdravkovic, Marija, et al.
Publicado: (2023)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma
por: Harrell, C. Randall, et al.
Publicado: (2019)

The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
por: Miloradovic, Dragana, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin
por: Harrell, C. Randall, et al.
Publicado: (2018)

Molecular mechanisms underlying therapeutic potential of pericytes
por: Harrell, C. Randall, et al.
Publicado: (2018)

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis
por: Arsenijevic, Aleksandar, et al.
Publicado: (2017)

Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
por: Harrell, Carl Randall, et al.
Publicado: (2020)

“Derived Multiple Allogeneic Protein Paracrine Signaling (d-MAPPS)” Enhances T Cell-Driven Immune Response to Murine Mammary Carcinoma
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
por: Gazdic, Marina, et al.
Publicado: (2017)

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
por: Simovic Markovic, Bojana, et al.
Publicado: (2017)

Ethical and Safety Issues of Stem Cell-Based Therapy
por: Volarevic, Vladislav, et al.
Publicado: (2018)

Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response
por: Gazdic, Marina, et al.
Publicado: (2017)

Exosomes Regulate NLRP3 Inflammasome in Diseases
por: Li, Zhangwang, et al.
Publicado: (2022)

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)

Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
por: Seok, Jin Kyung, et al.
Publicado: (2021)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease
por: Zhuang, Dian, et al.
Publicado: (2023)

Stem Cells Therapy for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2018)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Microbeam Radiotherapy—A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma
por: Trappetti, Verdiana, et al.
Publicado: (2021)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

SDF‐1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception
por: Dimova, Ivanka, et al.
Publicado: (2019)

Therapeutic Potential of d-MAPPS™ for Ocular Inflammatory Diseases and Regeneration of Injured Corneal and Retinal Tissue
por: Harrell, Carl Randall
Publicado: (2022)

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
por: Zhang, Xiaolu, et al.
Publicado: (2023)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o1vgcm4o7l3ijvqsd2v6cdd8th